One in two French people would not accept being vaccinated against Covid-19, according to an Odoxa-Dentsu poll, carried out for Franceinfo and Le Figaro.
- 60% of French people are opposed to the anti-covid vaccine being made compulsory.
- Only 17% of French people believe that the marketing of new vaccines means that we will be able to defeat the virus in the next 6 or 9 months.
Following announcements from Pfizer and BioNTech laboratories, only 1 in 2 French people intend to be vaccinated against Covid-19, according to a new Odoxa survey. 60% of us also oppose making it compulsory, as recently proposed by European Ecology-The Greens (EELV) MEP Yannick Jadot.
People are wary of vaccines in general
Only 17% of French people believe that the marketing of new vaccines means that we will be able to defeat the virus in the next 6 or 9 months. More generally, whole sections of the population are wary of vaccines in general: 31% cross-check their doctor’s opinion with other sources of information and 15% systematically refuse any type of vaccine (1 in 6 French people is a ” anti-vaccine”). In fact, France has long been one of the most anti-vaccine countries on the planet, hence the resurgence of deadly diseases such as measles.
In addition, the concern of the French with regard to Covid-19 has risen sharply since last September: 85% say they are worried about the health situation in the country (+6 points).
“90% effective”
Monday, November 9, the American pharmaceutical company Pfizer and its German counterpart BioNTech announced that they had jointly developed a vaccine against Covid-19. “90% effective”. These results, which must be confirmed at the end of November, come from the first interim analysis of their phase 3 trial still in progress, i.e. the final phase of trials before an application for approval.
“More than eight months after the start of the worst pandemic in more than a century, we believe this milestone represents a significant step forward for the world in our battle against Covid-19,” said Pfizer Chairman and CEO Albert Bourla. He added : “The first set of results from our Phase 3 Covid-19 vaccine trial provides initial evidence of our vaccine’s ability to prevent Covid-19.”
The vaccine race continues for many other companies, including the American laboratory Moderna, which are also conducting Phase 3 trials. China and Russia have decided to vaccinate their population before the end of phase 3, which is illegal in Europe.
.
